Barely Significant
← all phrases

indeterminate significance

138 sentences · 138 papers · 164 search hits before verification · confirmed specimen

Sighted at

p=0.08

Listed by Hankins (2013) · Otte et al. (2022)

In the literature

After a while it becomes necessary for him to take refuge in the no man’s land of “dysplasia” and other “entities of unknown or indeterminate significance” and, compiling data for “predicting outcome,” he becomes something like a haruspex, this diviner of antiquity whose function was to predict, for the benefit of the Emperor (the clinician), the issue of a battle by reading in the viscerae of a sacrificed animal (the patient) ( Figure 1 ).
Predicting outcome: a fourfold delusion!
Dermatol Pract Concept · 2012 · PMC3663346
Nonspecific findings (defined as radiologic abnormalities of indeterminate significance requiring follow up as reported by the radiologist) were detected in 89 SIs (68 CT scans, 19 bone scans and two abdominal ultrasounds), which triggered a total of 138 follow-up radiological scans in 71 (42%) of the 168 patients that had initial Sis, including: CT scan (n = 75), ultrasound abdomen (n = 29), MRI liver (n = 14), bone scan (n = 4), chest X-ray (n = 5), bone X-ray (n = 5), MRI spine (n = 4) and PET scan (n = 2).
33 (9.19%) samples were classified as non-diagnostic (Bethesda I), 149 (41.50%) as benign (Bethesda II), 47 (13.10%) as atypia of indeterminate significance/follicular lesion of indeterminate significance (AUS/FLUS, Bethesda III), 7 (1.95%) as follicular neoplasm/suspicious for follicular neoplasm (FN/SFN, Bethesda IV), 17 (4.74%) as suspicious for malignancy (SUSP, Bethesda V), and 123 (29.53%) as malignant (Bethesda VI).
The term clonal hematopoiesis of indeterminate significance (CHIP) was introduced to describe individuals with a hematologic malignancy-associated somatic mutation in peripheral blood or bone marrow cells but without any other diagnostic criteria for a hematologic malignancy. 107 CHIP must be distinguished from myelodysplastic syndromes (MDS) by the absence
Clonal Hematopoiesis: Role in Hematologic and Non-Hematologic Malignancies.
Mediterr J Hematol Infect Dis · 2022 · PMC9448266
These cytological diagnoses are determined, as follows: 1) Bethesda I, nondiagnostic or unsatisfactory, 2) Bethesda II, benign, 3) Bethesda III, atypical of indeterminate significance or follicular lesion of indeterminate significance, 4) Bethesda IV, follicular neoplasm or suspicious for a follicular neoplasm, 5) Bethesda V, suspicious for malignancy, and 6) Bethesda VI, malignant.
Alteration in Malignancy Rate with the Introduction of Non-Invasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features (NIFTP) Since significant portions of noninvasive FVPTCs are categorized as atypia of indeterminate significance (AUS), suspicious for follicular neoplasm (SFN) and suspicious for malignancy (SUS), the greatest impact of this new nomenclature was expected in these categories [ 6 , 16 , 17 ].
We analyzed 2 groups of variants found in 8 genes with definitive evidence for HCM ( 3 ): sarcomeric variants P/LP specifically for HCM (SARC-HCM-P/LP) and rare sarcomeric variants of indeterminate significance (SARC-IND) with the potential to cause HCM, dilated cardiomyopathy (DCM), or have little impact on cardiomyopathy risk.